Skip to main content

Course info

Conferences and Meetings 2026 Highlights of ASH in Latin America

2026 Highlights of ASH in Latin America

Category: Conferences and Meetings
Short name: 2026 Highlights of ASH in Latin America
Course start date: 05/01/2026
Course end date: 05/02/2026
Enrol Me

Sections

General
0 activities

InstructionsTo claim certificate of completion for...
Demographics & Overall Survey
Thank you for taking part in a Highlights of ASH e...
Friday Sessions
Current Use of Immunotherapies for the Treatment of Multiple Myeloma in Latin America
Completion Hours for Current Use of Immunotherapies for the Treatment of Multiple Myeloma in Latin America
Improving Prognosis in High-Risk Adult ALL: The Role of CD-19 and CD-22 directed immunotherapy and BH3 mimetics
Completion Hours for Improving Prognosis in High-Risk Adult ALL: The Role of CD-19 and CD-22 directed immunotherapy and BH3 mimetics
Panel Discussion I
Completion Hours for Panel Discussion I
New Insights into Sickle Cell Disease in 2026
Completion Hours for New Insights into Sickle Cell Disease in 2026
Bleeding Disorders: Current Updates and Future Directions
Completion Hours for Bleeding Disorders: Current Updates and Future Directions
Panel Discussion II
Completion Hours for Panel Discussion II
From Orlando to Macondo: Addressing New Data in Aggressive Lymphomas
Completion Hours for From Orlando to Macondo: Addressing New Data in Aggressive Lymphomas
Treating the Acute Myeloid Leukemia Patients in 2026
Completion Hours for Treating the Acute Myeloid Leukemia Patients in 2026
Panel Discussion III
Completion Hours for Panel Discussion III
Tumor Board: Driving CARs Toward a Cure: CAR T for Hematologic Malignancies
Completion Hours for Tumor Board: Driving CARs Toward a Cure: CAR T for Hematologic Malignancies
Saturday Sessions
Recent Advances in Transplantation and Cellular Therapy Impacting Latin America
Completion Hours for Recent Advances in Transplantation and Cellular Therapy Impacting Latin America
A New “Targeted” Era of Myeloproliferative Neoplasms
Completion Hours for A New “Targeted” Era of Myeloproliferative Neoplasms
Panel Discussion IV
Completion Hours for Panel Discussion IV
Tumor Board: Bone Marrow Failure Syndromes: Inherited vs. Acquired - To Transplant or Not to Transplant?
Completion Hours for Tumor Board: Bone Marrow Failure Syndromes: Inherited vs. Acquired - To Transplant or Not to Transplant?
Challenges in Venous Thromboembolism Management
Completion Hours for Challenges in Venous Thromboembolism Management
Hemolysis, Thrombosis, and Complement: Advances in Pathophysiology and Management
Completion Hours for Hemolysis, Thrombosis, and Complement: Advances in Pathophysiology and Management
Panel Discussion V
Completion Hours for Panel Discussion V
T-Cell Lymphomas in 2026: From Biology Towards Personalized Medicine
Completion Hours for T-Cell Lymphomas in 2026: From Biology Towards Personalized Medicine
Advances in Therapeutic Strategies for Indolent Lymphomas and Chronic Lymphocytic Leukemia
Completion Hours for Practice Changing Advances in Myelodysplastic Syndromes and Myeloproliferative Neoplasms
Panel Discussion VI
Completion Hours for Panel Discussion VI
Please complete the Demographic & Overall Survey a...
Download Certificate of Completion
Text and media area Text and media area
5
Questionnaire Questionnaire
21
Credit activity Credit activity
20
Certificate Certificate
1
Enrol Me
Accreditation
Not Accredited
Credit Type and Amount

  • 12.5 Completion Hours
Learning Format
Live
Location
Bogotá, Colombia
Activity date(s)
1 May 2026